• Teladoc Health Inc TDOC.N reported a quarterly adjusted loss of 28 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -17 cents. The mean expectation of twenty six analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -36 cents to -15 cents per share.

• Revenue fell 3% to $640.49 million from a year ago; analysts expected $639.55 million.

• Teladoc Health Inc's reported EPS for the quarter was a loss of 28 cents​.

• The company reported a quarterly loss of $48.41 million.

• Teladoc Health Inc shares had risen by 23.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.6% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy," 21 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the healthcare facilities & services peer group is also "hold"

Wall Street's median 12-month price target for Teladoc Health Inc is $10.50

This summary was machine generated from LSEG data February 26 at 10:57 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)